Aware Super Pty Ltd as trustee of Aware Super Invests $48.86 Million in HCA Healthcare, Inc. $HCA

Aware Super Pty Ltd as trustee of Aware Super acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 103,254 shares of the company’s stock, valued at approximately $48,864,000. HCA Healthcare comprises about 0.7% of Aware Super Pty Ltd as trustee of Aware Super’s investment portfolio, making the stock its 23rd biggest position.

Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Sumitomo Life Insurance Co. boosted its position in shares of HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after buying an additional 20 shares in the last quarter. MJP Associates Inc. ADV raised its position in HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after acquiring an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC grew its position in shares of HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after purchasing an additional 21 shares during the last quarter. Anchyra Partners LLC raised its position in shares of HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after purchasing an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd grew its holdings in HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after buying an additional 22 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on HCA shares. JPMorgan Chase & Co. reduced their price objective on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 19th. Leerink Partners reduced their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a report on Tuesday, April 28th. Weiss Ratings lowered shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Finally, Royal Bank Of Canada cut their price target on HCA Healthcare from $534.00 to $435.00 and set an “outperform” rating for the company in a report on Wednesday. Fourteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $486.14.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $385.71 on Friday. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The company has a market cap of $85.57 billion, a price-to-earnings ratio of 13.26, a price-to-earnings-growth ratio of 1.25 and a beta of 1.12. The stock’s 50-day moving average is $393.51 and its 200-day moving average is $457.65.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the previous year, the business posted $6.45 EPS. The company’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 29.77 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Some analysts remain constructive, with one Seeking Alpha piece arguing HCA’s recent underperformance may already reflect the biggest policy and margin concerns, and that the stock could be set up for a rebound if fundamentals stabilize.
• Neutral Sentiment: Barclays lowered its price target on HCA Healthcare from $427 to $402 and kept an equal-weight rating, signaling a more cautious near-term view even though the new target still implies modest upside from current levels. Barclays Cuts HCA Price Target
• Neutral Sentiment: Several articles noted that HCA’s stock still looks discounted relative to its long-term earnings power, but valuation arguments may be offset by growing concerns around reimbursement pressure and insurance coverage losses.
• Negative Sentiment: HCA cut its 2026 earnings outlook after reporting that federal policy changes, a worsening payer mix, and more uninsured patients could reduce profits by roughly $1 billion, raising concerns about margin compression and slower growth. HCA Cuts 2026 Earnings Forecast
• Negative Sentiment: Reports also highlighted a $400 million hit linked to policy changes and weaker earnings quality, since part of the quarterly beat was helped by a one-time Medicaid payment rather than underlying operating strength.
• Negative Sentiment: Labor and contract issues at one HCA hospital added another headline risk, though this appears less material than the company’s earnings and policy-related pressures.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.